88 related articles for article (PubMed ID: 25487531)
1. Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection.
Semmo N; Weber T; Idle JR; Beyoğlu D
J Viral Hepat; 2015 Jul; 22(7):617-24. PubMed ID: 25487531
[TBL] [Abstract][Full Text] [Related]
2. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
Sato S; Genda T; Ichida T; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
J Gastroenterol Hepatol; 2016 Jul; 31(7):1315-22. PubMed ID: 26758591
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers.
Reddy KA; Kumar PU; Srinivasulu M; Triveni B; Sharada K; Ismail A; Reddy GB
Breast; 2017 Feb; 31():137-143. PubMed ID: 27855345
[TBL] [Abstract][Full Text] [Related]
4. Hepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis C.
Boštjančič E; Bandelj E; Luzar B; Poljak M; Glavač D
J Viral Hepat; 2015 Feb; 22(2):146-57. PubMed ID: 25065618
[TBL] [Abstract][Full Text] [Related]
5. Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection.
Berzsenyi MD; Roberts SK; Preiss S; Woollard DJ; Beard MR; Skinner NA; Bowden DS; Visvanathan K
J Viral Hepat; 2011 Dec; 18(12):852-60. PubMed ID: 21050341
[TBL] [Abstract][Full Text] [Related]
6. Tracer metabolomics reveals the role of aldose reductase in glycosylation.
Radenkovic S; Ligezka AN; Mokashi SS; Driesen K; Dukes-Rimsky L; Preston G; Owuocha LF; Sabbagh L; Mousa J; Lam C; Edmondson A; Larson A; Schultz M; Vermeersch P; Cassiman D; Witters P; Beamer LJ; Kozicz T; Flanagan-Steet H; Ghesquière B; Morava E
Cell Rep Med; 2023 Jun; 4(6):101056. PubMed ID: 37257447
[TBL] [Abstract][Full Text] [Related]
7. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury.
Mihm S; Fayyazi A; Ramadori G
Hepatology; 1997 Aug; 26(2):451-8. PubMed ID: 9252158
[TBL] [Abstract][Full Text] [Related]
8. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
Cribier B; Rey D; Uhl G; Le Coz C; Hirth C; Libbrecht E; Vetter D; Lang JM; Stoll-Keller F; Grosshans E
Arch Dermatol; 1996 Dec; 132(12):1448-52. PubMed ID: 8961873
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
10. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M
J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
[TBL] [Abstract][Full Text] [Related]
11. IL-4 and reactive oxygen species are elevated in Egyptian patients affected with schistosomal liver disease.
Elsammak MY; Al-Sharkaweey RM; Ragab MS; Amin GA; Kandil MH
Parasite Immunol; 2008; 30(11-12):603-9. PubMed ID: 19067841
[TBL] [Abstract][Full Text] [Related]
12. Plasma Insulin/Erythrocytic Aldose Reductase Ratio as a Predictor for Hepatocellular Carcinoma among Type II Diabetics and Hepatitis C Virus-infected Patients.
Abdel-Hamid NM; Sherif MH; Al Samahy AE; Abdelhamid MS
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3815-3823. PubMed ID: 36444594
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
14. Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids.
Endo S; Matsunaga T; Mamiya H; Ohta C; Soda M; Kitade Y; Tajima K; Zhao HT; El-Kabbani O; Hara A
Arch Biochem Biophys; 2009 Jul; 487(1):1-9. PubMed ID: 19464995
[TBL] [Abstract][Full Text] [Related]
15. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
Heringlake S; Hofdmann M; Fiebeler A; Manns MP; Schmiegel W; Tannapfel A
J Hepatol; 2010 Feb; 52(2):220-7. PubMed ID: 20036025
[TBL] [Abstract][Full Text] [Related]
16. Sensitive, selective gas chromatographic-mass spectrometric analysis with trifluoroacetyl derivatives and a stable isotope for studying tissue sorbitol-producing activity.
Kishimoto M; Kajimoto Y; Kubota M; Watarai T; Shiba Y; Kawamori R; Inaba T; Kamada T; Yamasaki Y
J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(1):1-10. PubMed ID: 9029308
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B and C in internally displaced persons of war against terrorism in Swat, Pakistan.
Rauf A; Nadeem MS; Ali A; Iqbal M; Mustafa M; Latif MM; Latif MZ; Ahmed N; Shakoori AR
Eur J Public Health; 2011 Oct; 21(5):638-42. PubMed ID: 20601693
[TBL] [Abstract][Full Text] [Related]
18. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
